SeerPharma Pty Ltd :: DISCover web-based training

Depression (MDD): Treatment

Description: The diagnosis for depression is termed Major Depressive Disorder (MDD) and is one of the most prevalent mental illnesses, affecting an estimated 17% of the world population at some point in their lifetime. A heterogeneous and complicated mood disorder, depression can wreak havoc on an individual and, in the most tragic cases, can culminate in suicide. The treatment options for MDD are discussed in this course.

COURSE OUTLINE

INTRODUCTION
1. Course Information
2. Interface Tour
3. Course Overview

PHARMACOTHERAPYharmacotherapy
4. Objectives
5. Pharmacological Summary
6. Tricyclic Antidepressants
7. Monoamine Oxidase Inhibitors
8. SSRIs
9. Progress Check

NON-PHARMACOLOGICAL THERAPY
10. Objectives
11. Electroconvulsive Shock Treatment
12. Psychotherapy
13. Progress Check

PROGNOSIS
14. Objectives
15. Associated Complications
16. Associated Comorbid Conditions
17. Progress Check

CONCLUSION
18. Summary

COURSE OBJECTIVES

Students completing this course should be able to:

List and describe the main classes of drugs used in the treatment of MDD
Explain the mechanism of actions for each pharmacological agent presented
Summarize the underlying mechanism, indications and contraindications, and side effects of electroconvulsive therapy (ECT)
Summarize the underlying mechanism, indications and contraindications, and side effects of vagal nerve stimulation (VNS)
Discuss the role of psychotherapy in the treatment of MDD
Discuss the complications associated with the progression of MDD
List the comorbid disorders commonly seen in patients with MDD

Home

Training Programs

Upcoming Training

Compliance Consulting

DISCover e-Learning

Modules available

SOPtrain

Quality Management Software

Clinical Trials Software

SeerPharma has partnered with GeneEd to now distribute courses in Major Therapeutic Areas, Clinical Research, and Biotechnology & Genetics.